Compare Mutual Funds
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
1.1
-
NAV
₹12.17
-
Fund Started
08 Apr 2024
-
Fund Size
₹158.34 Cr
-
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
-
1 Year
9.31%
-
3 Year
-
-
5 Year
-
-
Equity
101.41%
-
Cash
-1.41%
-
Top 10 Holdings
Lupin Ltd. | 10.41% |
Fortis Healthcare Ltd. | 9.17% |
Laurus Labs Ltd. | 7.80% |
Aurobindo Pharma Ltd. | 6.37% |
Alkem Laboratories Ltd. | 6.16% |
Glenmark Pharmaceuticals Ltd. | 6.00% |
Biocon Ltd. | 5.19% |
Mankind Pharma Ltd. | 4.74% |
Ipca Laboratories Ltd. | 3.97% |
Krishna Institute of Medical Sciences Ltd | 3.43% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
-
Launch Date
08 Apr 2024
-
